Clinical trialNCT06598462Active, not recruitingPhase 2Interventional

A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis

SponsorUniquity One (UNI)Enrollment184Eosinophilic Esophagitis (EoE)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew W Lee, MD
Vice President, Clinical Research
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site 1108
Newcastle, New South Wales, Australia
Research Site 1110
Maroochydore, Queensland, Australia
Research Site 1103
South Brisbane, Queensland, Australia
Research Site 1107
Woolloongabba, Queensland, Australia
Research Site 1106
Box Hill, Victoria, Australia
Research Site 1102
Fitzroy, Victoria, Australia
Research Site 1101
Parkville, Victoria, Australia
Research Site 1109
Murdoch, Western AUS, Australia
Research Site 1111
Maroochydore, Australia
Research Site 1107
Woolloongabba, Australia

Belgium

Research Site 1151
Leuven, VLG, Belgium
Research Site 1152
Bruges, Belgium
Research Site 1153
Tournai, Belgium

Italy

Research Site 1252
Milan, Ca'Granada, Italy
Research Site 1256
Campobasso, IT, Italy
Research Site 1253
Padova, IT, Italy
Research Site 1255
Roma, IT, Italy
Research Site 1259
Pieve Emanuele, MI, Italy
Research Site 1258
Verona, Italy

Netherlands

Research Site 1303
Maastricht, AZ, Netherlands
Research Site 1302
Rotterdam, Netherlands

Poland

Research Site 1207
Lodz, Poland
Research Site 1202
Szczecin, Poland
Research Site 1205
Tychy, Poland
Research Site 1201
Warsaw, Poland
Research Site 1203
Warsaw, Poland
Research Site 1204
Warsaw, Poland
Research Site 1206
Warsaw, Poland

Spain

Research Site 1354
Barcelona, Spain
Research Site 1352
Madrid, Spain
Research Site 1353
Madrid, Spain
Research Site 1351
Tomelloso, Spain

Switzerland

Research Site 1402
Zurich, Switzerland

United Kingdom

Research Site 1551
Whitechapel, London, United Kingdom
Research Site 1553
London, Tooting, United Kingdom

United States

Research Site 1039
Dothan, Alabama, United States
Research Site 1018
Glendale, Arizona, United States
Research Site 1018
Peoria, Arizona, United States
Research Site 1037
Scottsdale, Arizona, United States
Research Site 1003
Tucson, Arizona, United States

33 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Oct 2024
Primary completion: 30 Apr 2027
Completion: 31 Aug 2027
Last update posted: 20 Mar 2026
Registered enrollment: 184
Registry id: NCT06598462

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.